Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Principals of Topical BioMedics Attending World Premiere of Documentary “American Addict 2: The Big Lie"
  • USA - English


News provided by

Topical BioMedics, Inc.

Jul 16, 2015, 14:45 ET

Share this article

Share toX

Share this article

Share toX

American Addict 2: The Big Lie, digs deeper into the world of corruption, politics and pharmaceutical greed and includes shocking undercover footage
American Addict 2: The Big Lie, digs deeper into the world of corruption, politics and pharmaceutical greed and includes shocking undercover footage
Youtube
Youtube

Rhinebeck, NY (PRWEB) July 16, 2015 -- Lou Paradise, president and chief of research, and Aurora Paradise, chief operations officer of Topical BioMedics, Inc., (Topricin) are attending the World Premiere of the documentary American Addict 2: The Big Lie, on Thursday, July 16, 2015, in Los Angeles, California, at Sundance Cinemas. The company is a sponsor of the evening, and attendance at the event is by the invitation of Executive Producer Gregory A. Smith, M.D.

American Addict 2 is a landmark film exposing the issues, providing vital information that will educate the public and help to turn the tide away from deadly drugs.”

Post this

From the makers of the hit documentary American Addict, American Addict 2 picks up where the first film left off and breaks more new ground. Director Sasha Knezev conducts candid interviews with leading celebrities, politicians, and physicians, including Gregory A. Smith, M.D., who specializes in the integrative treatment of addiction. Following the impact of the first film, American Addict 2 digs deeper into the world of corruption, politics and pharmaceutical greed and includes shocking undercover footage. Matthew Perry, Jonathan Davis, Ron Paul and Dennis Kucinich contribute to this eye opening examination of America's deadly dependency with prescription medication. Link to the official movie trailer:    https://www.youtube.com/watch?v=E7RCtuGKGDo

“We are honored to support this important film,” says Mr. Paradise, who is a pain management expert. “The tragedy of the addiction epidemic has reached epic proportions, ruining lives, destroying families, eroding communities, and undermining the fabric of American society.

“For over 20 years, the Topricin project has assisted hundreds of thousands of people suffering with pain and those addicted to painkillers to achieve fully restored and robust healthy living. Formulated from a combination of natural biomedicines that stimulate and support the body’s own healing chemistries, Topricin is changing the way we treat pain.
Unfortunately, millions of people continue to suffer in pain and with addiction. American Addict 2 is a landmark film exposing the issues, providing vital information that will educate the public and help to turn the tide away from deadly drugs.”

In 2012, Dr. Smith founded Pain MD Productions, Inc., to facilitate the distribution of its first film, American Addict. “Every film we produce will deliver the truth,” says Dr. Smith. “We want to actually do something about the huge issues and problems we cover and expose. A percentage of the net revenue of each film will be donated to a non-profit corporation that pays the medical bills for patients who cannot afford treatment. We want to help fund research for the underfunded alternative methods of treating medical problems such as addiction and cancer.”

For more information about American Addict 2, visit http://www.americanaddictthemovie.com/

Links: Topical BioMedics: http://www.topicalbiomedics.com/; Topricin: http://www.Topricin.com; Pain MD Productions: http://www.painmdproductions.com/.

ABOUT TOPICAL BIOMEDICS
21 years in business and a Certified B Corporation, Topical BioMedics is a research and development leader in topical patented natural biomedicines for pain relief. The company’s flagship product, Topricin® Pain Relief and Healing Cream, was introduced in 1994 and is now a leading natural therapeutic brand. A combination natural biomedicine formula, Topricin has been awarded a patent for the treatment of pain associated with fibromyalgia and neuropathy. Topricin products are mandatory treatment protocol at world renowned medical centers.

The Topricin family of natural healing products also includes Topricin Foot Therapy Cream, specially formulated to treat painful foot and ankle issues and conditions, and Topricin for Children, which received the Parent Tested Parent Approved Seal of Approval (with 5% of sales are donated to pediatric cancer foundations). The company recently launched the new MyPainAway™ Powered by Topricin line of products.    

Made in the U.S.A., all Topricin products are federally-regulated over-the-counter medicines with no known side effects, no parabens, petroleum, or other harsh chemicals, no grease, and no odor.

For over 21 years, the company has assisted hundreds of thousands of people suffering with pain and those addicted to painkillers to get off of these, and achieve fully restored and robust healthy living. Unfortunately, millions of people continue to suffer in pain, and more people are finding the benefits of Topricin so to reduce or eliminate the hazardous side effects of OTC chemical pain pills and Rx opioid painkillers—while reversing the epidemic that has turned the lives of American families upside down as it rips at the very fabric of our country.

Because of the company’s experience in addressing these challenges, it has launched its “Get Relief, Give Relief” initiative: for every Topricin product purchased directly from the company, it will donate a tube of Topricin to a free pain clinic or charitable organization. To participate in “Get Relief, Give Relief,” order from http://www.topricin.com or call 1-800-LES-PAIN (537-7246).

Topical BioMedics launched a free monthly pain management webinar in February 2015. Featuring Lou Paradise, president, chief of research, and pain management expert, the webinars are streamed live the second Tuesday of each month from 12pm to 1pm then archived on the company’s WordPress blog for on-demand access 24/7. https://topricin.wordpress.com/

Topical BioMedics also offers TopTrack, a new app for on-the-go pain tracking and monitoring. TopTrack is available free of charge for iPad via the App Store, and will roll out on additional devices in the coming months. http://bit.ly/1rIQD89. This app allows the person in pain to record their monthly activity/pain levels following applications of Torpricin, enabling them to track their progress and experiences. For example: better sleep, reducing pain pills, along with healthy lifestyle tips so at the end of the month all the data can be downloaded and shared with your health care provider.

Topricin is available in independent pharmacies, natural food and co-op stores nationwide, including Whole Foods, Sprouts, Pharmaca, The Vitamin Shoppe, Fred Meyer, Wegmans, CVS (Foot Care Section), Walgreens (Diabetic Section), and other fine retailers, as well as directly from the company.

For more information visit http://www.topricin.com; http://www.topicalbiomedics.com.

Patricia Martin, Topical BioMedics, Inc., http://www.physical-knead.com, +1 845-876-8445, [email protected]

Modal title

Pain MD Products was founded by Gregory A. Smith, M.D., to distribute films that will make an impact and turn the addiction epidemic around while helping those in need
Pain MD Products was founded by Gregory A. Smith, M.D., to distribute films that will make an impact and turn the addiction epidemic around while helping those in need
Topical BioMedics is a research and development leader in topical patented natural biomedicines for pain relief, dedicated to changing the way we treat pain
Topical BioMedics is a research and development leader in topical patented natural biomedicines for pain relief, dedicated to changing the way we treat pain
Pain MD Products was founded by Gregory A. Smith, M.D., to distribute films that will make an impact and turn the addiction epidemic around while helping those in need Topical BioMedics is a research and development leader in topical patented natural biomedicines for pain relief, dedicated to changing the way we treat pain

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.